| A Systematic Review of Studies of the Effect of Influenza Vaccine Against Mismatched Strains (NCT01416597) | GlaxoSmithKline | 2011-08-01 |
| Long-term Safety Study for GSK573719/GW642444 in Japanese (NCT01376388) | GlaxoSmithKline | 2011-08-01 |
| Special Drug Use Investigation for Botox® (Botulinum) Spasticity (BOTOX is a Registered Trademark of Allergan, Inc.) (NCT01390922) | GlaxoSmithKline | 2011-08-01 |
| Meta-Analysis Plan for Pooled Data for Studies VRX-RET-E22-303 and VRX-RET-E22-304 (NCT01457989) | GlaxoSmithKline | 2011-08-01 |
| A Study to Evaluate the Safety and Immunogenicity of a Prime-boost Schedule of GSK Biologicals' Influenza Vaccine in Children (NCT01379937) | GlaxoSmithKline | 2011-07-28 |
| Tafenoquine Thorough QTc Study in Healthy Subjects (NCT01928914) | GlaxoSmithKline | 2011-07-26 |
| Study to Investigate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Single & Repeat Doses of GSK2269557 (NCT01462617) | GlaxoSmithKline | 2011-07-24 |
| Topiramate Bioequivalence Study Brazil - Fast (NCT01439438) | GlaxoSmithKline | 2011-07-22 |
| Inhalation of Corticosteroids in Smoking and Non-smoking Asthmatics. (NCT01400906) | GlaxoSmithKline | 2011-07-20 |
| A Study of GSK256073 in Subjects With Type 2 Diabetes Mellitus Who Are Being Treated With Metformin (NCT01376323) | GlaxoSmithKline | 2011-07-13 |
| An Investigation of the Pharmacokinetics of GSK961081 and Fluticasone Propionate in Healthy Volunteers (NCT01449799) | GlaxoSmithKline | 2011-07-13 |
| 12 Week Patient Study in Neovascular Age-related Macular Degeneration (AMD) (NCT01362348) | GlaxoSmithKline | 2011-07-07 |
| Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects (NCT01439373) | GlaxoSmithKline | 2011-07-07 |
| Albiglutide Thorough ECG Study in Healthy Volunteers (NCT01406262) | GlaxoSmithKline | 2011-07-06 |
| Evaluate the Efficacy and Safety of GSK573719 Delivered Via a Novel Dry Powder Inhaler in Subjects With COPD (NCT01387230) | GlaxoSmithKline | 2011-07-01 |
| Nicotine Lozenge Bioequivalence Study (NCT01536704) | GlaxoSmithKline | 2011-07-01 |
| Zanamivir Aqueous Solution Compassionate Use Program Retrospective Chart Review Study (NCT01353768) | GlaxoSmithKline | 2011-07-01 |
| Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents (NCT01362322) | GlaxoSmithKline | 2011-07-01 |
| Evaluating the Utility of the Apoptosis Imaging Biomarker 18F]ML10 in Patients With Non-Hodgkin's Lymphoma(NHL) (NCT01476085) | GlaxoSmithKline | 2011-07-01 |
| Safety of Inhaled Zanamivir in Pregnancy (NCT01462487) | GlaxoSmithKline | 2011-07-01 |
| A Randomized, Double Blind, Placebo Controlled, Incomplete Block, Crossover, Dose Ranging Study to Evaluate the Dose Response of GSK573719 Administered Once or Twice Daily Over 7 Days in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT01372410) | GlaxoSmithKline | 2011-07-01 |
| Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects (NCT01400932) | GlaxoSmithKline | 2011-07-01 |
| Pharmacokinetics/Pharmacodynamics of Albiglutide (NCT01357889) | GlaxoSmithKline | 2011-07-01 |
| [18F]PBR111 and Microglial Activation in Multiple Sclerosis (NCT01428505) | GlaxoSmithKline | 2011-07-01 |
| A Study to Compare the Impact of Fulticasone Furoate/Vilanterol vs. Tiotropium on Arterial Stiffness in COPD (NCT01395888) | GlaxoSmithKline | 2011-06-30 |
| Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males. (NCT01471678) | GlaxoSmithKline | 2011-06-30 |
| Infectious Pathogens in Acute Respiratory Illness in Adults and Elderly (NCT01360398) | GlaxoSmithKline | 2011-06-30 |
| Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls (NCT01381575) | GlaxoSmithKline | 2011-06-29 |
| GSK2251052 in Complicated Urinary Tract Infection (NCT01381549) | GlaxoSmithKline | 2011-06-28 |
| Evaluation of the Long-term Persistence of GlaxoSmithKline (GSK) Biologicals' Candidate Cytomegalovirus (CMV) Vaccine (NCT01357915) | GlaxoSmithKline | 2011-06-24 |
| Long-term Ambrisentan Extension Study for Pediatric Patients Who Participated in AMB112529 (NCT01342952) | GlaxoSmithKline | 2011-06-21 |
| Absolute Bioavialability of GSK1120212 (NCT01416337) | GlaxoSmithKline | 2011-06-20 |
| Bioequivalence Minocycline Bioequivalence (NCT01755611) | GlaxoSmithKline | 2011-06-17 |
| First Time in Human Study Using GSK2330672 (NCT01416324) | GlaxoSmithKline | 2011-06-15 |
| Determination of the Absolute Bioavailability of GSK2118436 Following a Single Oral Dose Co-Administered With an Intravenous Radiolabelled Microtracer of GSK2118436 in Subjects With BRAF Mutant Solid Tumors (NCT01340833) | GlaxoSmithKline | 2011-06-08 |
| GSK2190915 Neutrophilic Asthma Study (NCT01471665) | GlaxoSmithKline | 2011-06-01 |
| Immunization of Children Between 8 Weeks and 2 Years of Age With GSK Pneumococcal Vaccine GSK1024850A (NCT01175083) | GlaxoSmithKline | 2011-06-01 |
| Clinical Study to Investigate Safety and Efficacy of GSK933776 in Adult Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration (NCT01342926) | GlaxoSmithKline | 2011-06-01 |
| Cost of Illness Associated With Influenza in the UK (NCT01521416) | GlaxoSmithKline | 2011-06-01 |
| To Evaluate the Incidence of Acute Otitis Media in Children in Five East European Countries (NCT01365390) | GlaxoSmithKline | 2011-06-01 |
| Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™ (NCT01358825) | GlaxoSmithKline | 2011-05-30 |
| An Investigation of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2245035 in Healthy Volunteers and Allergic Rhinitics. (NCT01480271) | GlaxoSmithKline | 2011-05-30 |
| Amoxicillin Bioequivalence Study Brazil - Fast (NCT01431989) | GlaxoSmithKline | 2011-05-27 |
| GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia (NCT01345253) | GlaxoSmithKline | 2011-05-23 |
| Healthy Volunteer Study Using 3 Different Formulations of Firategrast (NCT01416363) | GlaxoSmithKline | 2011-05-20 |
| A Study to Evaluate the Effect of Intravenous Zanamivir on Cardiac Conduction in Healthy Volunteers (NCT01353729) | GlaxoSmithKline | 2011-05-19 |
| Consistency of Immunogenicity and Non Inferiority of GSK Biologicals' Candidate Malaria Vaccine Lots in Children (NCT01323972) | GlaxoSmithKline | 2011-05-16 |
| GSK1521498 Alcohol Interaction Study (NCT01366573) | GlaxoSmithKline | 2011-05-13 |
| Redirected Auto T Cells for Advanced Myeloma (NCT01352286) | GlaxoSmithKline | 2011-05-13 |
| Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male Subjects (NCT01577693) | GlaxoSmithKline | 2011-05-12 |
| GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease (NCT01316939) | GlaxoSmithKline | 2011-05-09 |
| Dose Response of 28 Days of Dosing of GSK962040 in Type I and II Diabetic Male and Female Subjects With Gastroparesis (NCT01262898) | GlaxoSmithKline | 2011-05-03 |
| GSK1120212 Food-effect Study (NCT01371487) | GlaxoSmithKline | 2011-05-02 |
| A Comparison of Solid and Soluble Forms of Cold and Influenza Remedies (NCT01332578) | GlaxoSmithKline | 2011-05-01 |
| An Observational Study to Assess the Burden of Drug-resistant Partial Epilepsy in Italy (NCT01332539) | GlaxoSmithKline | 2011-05-01 |
| Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias (NCT00920140) | GlaxoSmithKline | 2011-05-01 |
| WEUSKOP5410: Observational Study in ENABLE Clinical Trials (NCT01458080) | GlaxoSmithKline | 2011-05-01 |
| A Study to Determine the Excretion Balance and Pharmacokinetics of 14C-GSK573719 (NCT01362257) | GlaxoSmithKline | 2011-04-29 |
| Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated Children (NCT01333813) | GlaxoSmithKline | 2011-04-26 |
| Immunogenicity and Safety of Booster Dose of PoliorixTM Vaccine in Previously Vaccinated Toddlers (NCT01323647) | GlaxoSmithKline | 2011-04-25 |
| GSK2251052 Mass Balance in Healthy Adult Subjects (NCT01475695) | GlaxoSmithKline | 2011-04-21 |
| Study to Evaluate the Immunogenicity and Safety of an Investigational Pandemic Influenza Vaccine in Children (NCT01323946) | GlaxoSmithKline | 2011-04-18 |
| Lamotrigine Bioequivalence Study to Compare Dispersible Tables With Compressed Tablets in China (NCT01357902) | GlaxoSmithKline | 2011-04-18 |
| Intranasal SB-705498 in Allergic Rhinitis (AR) Patients (NCT01424397) | GlaxoSmithKline | 2011-04-14 |
| A Study Assessing GW870086's Potential to Cause Skin Thinning (NCT01381445) | GlaxoSmithKline | 2011-04-14 |
| Evaluation of an Anti-cancer Immunotherapy Combined With Standard Neoadjuvant Treatment in Patients With WT1-positive Primary Invasive Breast Cancer (NCT01220128) | GlaxoSmithKline | 2011-04-11 |
| A Study to Investigate the Effect of SB-705498 on Chronic Cough (NCT01476098) | GlaxoSmithKline | 2011-04-01 |
| A 24-week Study of Fluticasone Furoate/Vilanterol Inhalation Powder in Subjects of Asian Ancestry With COPD (NCT01376245) | GlaxoSmithKline | 2011-04-01 |
| Open-Label Extension Study of GSK1605786A (NCT01318993) | GlaxoSmithKline | 2011-04-01 |
| Immunogenicity and Safety of GSK Biologicals' Boostrix Polio Vaccine in 3 and 4-year-old Children (NCT01245049) | GlaxoSmithKline | 2011-04-01 |
| Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults (NCT01323959) | GlaxoSmithKline | 2011-04-01 |
| Safety Evaluation of the GSK-580299 Vaccine in Women From the Control Group in the Primary NCT00294047 Study (NCT01190189) | GlaxoSmithKline | 2011-04-01 |
| Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of GSK1278863A in Healthy Subjects (NCT02348372) | GlaxoSmithKline | 2011-03-31 |
| Study in Allergic Adults to Support the Development of Immunological Assays (NCT01320137) | GlaxoSmithKline | 2011-03-31 |
| Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB) (NCT01300234) | GlaxoSmithKline | 2011-03-30 |
| A Single and Repeat Dose PK/PD Study to Characterise Biomarker Response in Healthy Subjects Treated With Azithromycin (NCT01416350) | GlaxoSmithKline | 2011-03-30 |
| GSK2239633 FTIH Study (NCT01371812) | GlaxoSmithKline | 2011-03-29 |
| Bioequivalence Study of an Amoxicillin-Clavulanic (NCT01772238) | GlaxoSmithKline | 2011-03-22 |
| Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (NCT01323634) | GlaxoSmithKline | 2011-03-18 |
| Study Evaluating the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT01323621) | GlaxoSmithKline | 2011-03-18 |
| An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444.Study B (NCT01323660) | GlaxoSmithKline | 2011-03-16 |
| Epidemiology Study of Malaria Transmission Intensity in Africa (NCT01190202) | GlaxoSmithKline | 2011-03-14 |
| Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects. (NCT01476046) | GlaxoSmithKline | 2011-03-08 |
| Monovalent H5N1 Vaccine GSK1557484A in Children 6 Months to < 18 Years of Age (NCT01310413) | GlaxoSmithKline | 2011-03-07 |
| Immunogenicity and Safety of GlaxoSmithKline Biologicals' Infanrix™-IPV+Hib Vaccine (NCT01309646) | GlaxoSmithKline | 2011-03-04 |
| A 24-week Arterial Stiffness Study With Fluticasone Furoate/Vilanterol in COPD (NCT01336608) | GlaxoSmithKline | 2011-03-04 |
| Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (Pharmetrics) (NCT01381601) | GlaxoSmithKline | 2011-03-01 |
| Outcomes for Chronic Obstructive Pulmonary Disease Moderate Exacerbators Initiating Treatment (NCT01395875) | GlaxoSmithKline | 2011-03-01 |
| An Exercise Endurance Study to Evaluate the Effects of Treatment of Chronic Obstructive Pulmonary Disease (COPD) Patients With a Dual Bronchodilator: GSK573719/GW642444. Study A (NCT01328444) | GlaxoSmithKline | 2011-03-01 |
| Epidemiological, Observational and Post Marketing Study of Rotarix™ in Children With Severe Gastroenteritis in Belgium (NCT01339221) | GlaxoSmithKline | 2011-03-01 |
| A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPD (NCT01313650) | GlaxoSmithKline | 2011-03-01 |
| 24-week Trial Comparing GSK573719/GW642444 With GSK573719 and With Tiotropium in Chronic Obstructive Pulmonary Disease (NCT01316913) | GlaxoSmithKline | 2011-03-01 |
| A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD (NCT01313637) | GlaxoSmithKline | 2011-03-01 |
| 24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease (NCT01316900) | GlaxoSmithKline | 2011-03-01 |
| SUrvey of Guideline Adherence for Treatment of Systolic Heart Failure in Real World (NCT01390935) | GlaxoSmithKline | 2011-03-01 |
| Incidence, Prevalence, and Symptom Burden Associated With Advanced Renal Cell Carcinoma in Commercially Insured Population (IHCIS) (NCT01381614) | GlaxoSmithKline | 2011-03-01 |
| Study of Long Term Immune Responses and Safety of the GSK Herpes Zoster Vaccine in Healthy Subjects (NCT01295320) | GlaxoSmithKline | 2011-02-28 |
| Relative Bioavailability Study for GSK1278863A (NCT01319006) | GlaxoSmithKline | 2011-02-25 |
| Bioequivalence Study for Terbinafine 250 mg (NCT01772212) | GlaxoSmithKline | 2011-02-24 |
| Lamivudine and Adefovir Dipivoxil Fixed Dose Combination (NCT01353742) | GlaxoSmithKline | 2011-02-21 |